Sandoz’ Ziextenzo And Riximyo Cleared In Canada

Company Has Portfolio Of Five Biosimilars Planned For 2021

 
• By Dean Rudge
  
CanadianFlags
Sandoz is eyeing a portfolio of five biosimilars in Canada • Source: Shutterstock

More from Biosimilars

More from Products